New Jersey-based Johnson & Johnson says it's one-dose covid vaccine does not protect as well as its two-shot competitors, but it's still 66% effective overall.
New Jersey-based Johnson & Johnson says it's one-dose covid vaccine does not protect as well as its two-shot competitors, but it's still 66% effective overall.
Johns Hopkins researchers update on the vaccine rollout in America.